Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial

Clinical trial NCT07021534 · RECRUITING

Trial details

NCT number: NCT07021534
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments

Start date: 2025-06-10
Primary completion: 2026-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.